The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,284
Sort by:
Paresthesia Treatment Market Forecasts to 2034 – Global Analysis By Type (Chronic Paresthesia, Acute Paresthesia and Other Types), Treatment (Tropical Creams, Anticonvulsants, Immunosuppressant, Antivirals and Other Treatments), Cause, Distribution Channel, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Paresthesia Treatment Market is accounted for $6.3 billion in 2026 and is expected to reach $9.8 billion by 2034 growing at a CAGR of 5.6% during the forecast...
April 2026
200 pages
Paronychia Treatment Market Forecasts to 2034 – Global Analysis By Product (Mupirocin Ointment, Gentamicin Ointment, Fusidic Acid Ointment, Dicloxacillin and Other Products), Type (Chronic Paronychia, Acute Paronychia, Pyogenic Paronychia, Candidal Paronychia and Other Types), End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Paronychia Treatment Market is accounted for $660.6 million in 2026 and is expected to reach $1335.8 million by 2034 growing at a CAGR of 9.2% during the forec...
April 2026
200 pages
Turner Syndrome Market Forecasts to 2034 – Global Analysis By Type (Mosaic Turner Syndrome and Classical Turner Syndrome), Drug Type (Oxandrolone, Oxandrin, Norditropin, Somatropin, Genotropin, Humatrope, Zomacton and Nutropin), Therapy Type, Diagnosis, Route Of Administration, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Turner Syndrome Market is accounted for $5.3 billion in 2026 and is expected to reach $9.8 billion by 2034 growing at a CAGR of 8.1% during the forecast period...
April 2026
200 pages
Urinary Tract Infection Market Forecasts to 2034 – Global Analysis By Product (Azoles and Amphotericin B, Cephalosporin, Nitrofurans, Penicillin and Combinations, Quinolones and Other Products), Treatment Type, Test Type, Indication, Distribution Channel, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Urinary Tract Infection Market is accounted for $8.2 billion in 2026 and is expected to reach $14.9 billion by 2034 growing at a CAGR of 7.67% during the forec...
April 2026
200 pages
Appetite Stimulant Market Size, Share & Trends Analysis Report By Pharmacological Class (Cannabinoids & CNS-Acting Agents, Anabolic & Metabolic Agents), By Indication, By Route of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global appetite stimulant market size was estimated at USD 1.73 billion in 2025 and is projected to reach USD 2.90 billion by 2033, growing at a CAGR of 6.76% from 2026 to 2033. The market address...
April 2026
150 pages
Solid Dosage Form Market Forecasts to 2034 – Global Analysis By Dosage Form (Tablets, Capsules, Powders & Granules, Lozenges & Pastilles, Pellets & Mini-Tablets, Orally Disintegrating Films, and Other Dosage Forms), Drug Release, Route of Administration, Therapeutic Area, Manufacturing Process, Drug Type, Patient Demographics, End User, Distribution Channel, and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Solid Dosage Form Market is accounted for $1113.6 billion in 2026 and is expected to reach $1856.9 billion by 2034 growing at a CAGR of 6.6% during the forecas...
April 2026
200 pages
Congenital Adrenal Hyperplasia Treatment Market - 2025
US$ 2,999.00
The Congenital Adrenal Hyperplasia Treatment Market was valued at US$ 0.27 billion in 2025 and is anticipated to reach by , at a CAGR of 0.066 from 2026 to 2032. The report delivers in-depth insights...
April 2026
219 pages
Congenital Hyperinsulinism Treatment Market - 2025
US$ 2,999.00
The Congenital Hyperinsulinism Treatment Market was valued at USD 171.9 million in 2025 and is anticipated to reach by , at a CAGR of 0.055 from 2026 to 2032. The report delivers in-depth insights int...
April 2026
200 pages
Neurofibromatosis Type 2 Market 2026
US$ 2,999.00
The Neurofibromatosis Type 2 Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regi...
April 2026
218 pages
Charcot-Marie-Tooth (CMT) Disease Market - 2025-2033
US$ 2,999.00
The Charcot-Marie-Tooth (CMT) Disease Market was valued at US$ 746.99 Million in 2025 and is anticipated to reach US$ 1,166.98 Million by 2033, at a CAGR of 0.058 from 2026 to 2032. The report deliver...
April 2026
220 pages
Compartment Syndrome Treatment Market - 2025-2033
US$ 2,999.00
The Compartment Syndrome Treatment Market was valued at US$ 356.7 million in 2025 and is anticipated to reach US$ 583.2 million by 2033, at a CAGR of 0.063 from 2026 to 2032. The report delivers in-de...
April 2026
210 pages
Epidural Abscess Treatment Market - 2025-2033
US$ 2,999.00
The Epidural Abscess Treatment Market was valued at USD 52.65 billion in 2025 and is anticipated to reach USD 105.12 billion by 2033, at a CAGR of 0.09 from 2026 to 2032. The report delivers in-depth...
April 2026
218 pages
Limb-Girdle Muscular Dystrophy Market - 2023-2031
US$ 2,999.00
The Limb-Girdle Muscular Dystrophy Market was valued at US$ 1.3 billion in 2023 and is anticipated to reach US$ 2.4 billion by 2031, at a CAGR of 0.074 from 2026 to 2032. The report delivers in-depth...
April 2026
217 pages
Opioid Induced Constipation Treatment Market - 2025-2033
US$ 2,999.00
The Opioid Induced Constipation Treatment Market was valued at US$ 1,241.90 million in 2025 and is anticipated to reach US$ 1,835.00 million by 2033, at a CAGR of 0.05 from 2026 to 2032. The report de...
April 2026
217 pages
Global Eletriptan Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
... are 15 Chapters to deeply display the global Eletriptan market. Chapter 1, to describe Eletriptan Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the ...
April 2026
88 pages
Global Vinca Alkaloid API Market Growth 2026-2032
US$ 3,660.00
The global Vinca Alkaloid API market size is predicted to grow from US$ 130 million in 2025 to US$ 214 million in 2032; it is expected to grow at a CAGR of 7.5% from 2026 to 2032. Vinca alkaloids are...
April 2026
116 pages
Global Pharma Grade Ethyl Oleate Market Growth 2026-2032
US$ 3,660.00
The global Pharma Grade Ethyl Oleate market size is predicted to grow from US$ 40.46 million in 2025 to US$ 62.09 million in 2032; it is expected to grow at a CAGR of 6.4% from 2026 to 2032. Ethyl Ole...
April 2026
104 pages
Global Polypeptide API Market Growth 2026-2032
US$ 3,660.00
The global Polypeptide API market size is predicted to grow from US$ 8387 million in 2025 to US$ 15420 million in 2032; it is expected to grow at a CAGR of 9.3% from 2026 to 2032. Polypeptide API is t...
April 2026
134 pages
Global Pharma Grade Zein Market Growth 2026-2032
US$ 3,660.00
The global Pharma Grade Zein market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. United States market for Pharma G...
April 2026
84 pages
Global GLP-1 Drug Peptide API Market Growth 2026-2032
US$ 3,660.00
The global GLP-1 Drug Peptide API market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. GLP-1 (Glucagon-Like Peptide...
April 2026
95 pages
Global Triptans Supply, Demand and Key Producers, 2026-2032
US$ 4,480.00
The global Triptans market size is expected to reach $ 1663 million by 2032, rising at a market growth of 3.8% CAGR during the forecast period (2026-2032). Triptans are a class of selective 5-HT1B/1D...
April 2026
195 pages
Japan Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size, Share & Trends Analysis Report By Action of Mechanism (Complement Inhibitors, Supportive Care, Others), By Route of Administration, By End Use, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The Japan paroxysmal nocturnal hemoglobinuria treatment market size was valued at USD 279.95 million in 2025 and is projected to reach USD 455.53 million by 2033, growing at a CAGR of 5.88% from 2026...
April 2026
150 pages
Neuropathic Pain Market Size, Share & Trends Analysis Report By Drug Class, (Anticonvulsants, Antidepressants), By Indication (Diabetic Peripheral Neuropathy, Postherpetic Neuralgia), By Route of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global neuropathic pain market size was estimated at USD 8.53 billion in 2025 and is projected to reach USD 15.23 billion by 2033, growing at a CAGR of 7.58% from 2026 to 2033. The neuropathic pai...
April 2026
150 pages
